The Venture Codex Logo

The Venture Codex

Biospring Partners

40 W 57th St, 18th Floor, Suite 1815, New York, NY, 10019, United States

Overview

Growth equity firm investing in life sciences technology and innovation.

Founded

2020

Deals ยท 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

United States

Sector focus

Artificial Intelligence (AI)
Health Care
Information Technology
Internet
...

Investment portfolio

4rounds
NAMEDATESIZE
Labviva
Jan 2025Participated
$25 MSeries B
Labviva
Mar 2023Led
$20 MSeries A
PathAI
May 2021Participated
$165 MSeries C
Abzena
Jul 2020Led
$10 MOther Equity
Labviva
Jan 2025Participated
$25 MSeries B
Labviva
Mar 2023Led
$20 MSeries A
PathAI
May 2021Participated
$165 MSeries C
Abzena
Jul 2020Led
$10 MOther Equity
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Biospring Partners: 4 funding rounds are recorded in the selected participation categories.All available history.
Biospring Partners: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Series B01
Series C+01
Other Equity10

Monthly Deal Activity

Biospring Partners: 4 deals are recorded across 76 months.All available history.
Biospring Partners: 4 deals are recorded across 76 months. All available history
MonthDeals
Jul '201
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Biospring Partners: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Biospring Partners: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
E-Commerce & Retail2
Transportation & Logistics2

Deal Size Distribution

Biospring Partners: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Biospring Partners: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M1
$50M-$100M0
$100M-$250M1
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Biospring Partners: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Biospring Partners: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Biospring Partners: 17 co-investors are shown, with B Capital Group sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Biospring Partners: 17 co-investors are shown, with B Capital Group sharing 2 recorded deals. All available history
Co-investorShared deals
B Capital Group2
Glasswing Ventures2
53 Stations1
8VC1
Adage1
Bristol Myers Squibb1
D1 Capital Partners1
General Atlantic1
General Catalyst1
GHI1
Kaiser Permanente1
KdT Ventures1
Labcorp1
Polaris Partners1
Refactor Capital1
Senator Investment Group1
Tiger Global1

Investment Strategy

Biospring Partners: Led accounts for 50% and participating for 50% of round participation.All available history.
Biospring Partners: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led250%
Participating250%
Biospring Partners: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Biospring Partners: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead2100%
Co-led00%

Team

Drew Pearson

Head of Portfolio Management

Jennifer Lum

Co-Founder & Managing Partner

Michelle Detwiler

Co-Founder and Managing Partner